We first tested the effect of the MTH1 inhibitors TH588 and SCH51344 on the clonogenic survival of KNS42, SF188, U87, and normal fibroblasts and found that the glioblastoma were sensitive to the inhibition of MTH1 activity, while normal fibroblasts were barely affected. This evidence concerns the gene NUDT1 and glioblastoma.